Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: B.D. who wrote (24990)	8/29/1998 10:04:00 AM
From: roy whitt	Read Replies (2) \| Respond to of 32384

This is just my thoughts. what we have right now is a very bad bear market in the Bio-techs. IT HURTS REAL BAD.I posted some thoughts on the isis board too. what we need now is some cool heads and not to panic. to my understanding there is what 50 billion standing on the sidelines waiting for this to come to a end, I am one of them too. when the money starts to come back into the bio-techs ( this is just my opinion) I think companys like Isis and Centacorr or Corr which now have drugs approved Ligand by then should have there first drug approved I feel that these will be the companys that investors and fund managers will be looking at. companys with approved product and drugs in the late stage of phase lll testing. this is where I am going to be. I have been in Ligand for a long time im going to ride it out no reason to leave yet. I just added Isis back into my portfolio and xoma <--real risky) along with my Cypros holdings. I am looking at Vical, Chir, Btgc. all off these companys have been taken to the woodshed.of all of them vical and xoma I feel are the risky ones. Chir and Bio=tech general have approved products. cyros has already 5 approved products. and 2 in late stage testing. good luck to all the longs... my best advice is not to look at the stock price every day go drink a beer and have somefun... enjoy life...